A randomized controlled trial of add-back estrogen or placebo on cognition in men with prostate cancer receiving an antiandrogen and a gonadotropin-releasing hormone analog

Psychoneuroendocrinology

Volumn 35, Issue 2, 2010, Pages 215-225

  Matousek, Rose H ^a   Sherwin, Barbara B ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cognition; Combined androgen blockade; Estrogen; Gonadotropin releasing hormone analog; Prostate cancer; Randomized controlled trial

Indexed keywords

BICALUTAMIDE; ESTRADIOL; GOSERELIN; LEUPRORELIN; PLACEBO; SEX HORMONE BINDING GLOBULIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTIANDROGEN THERAPY; ARTICLE; BREAST DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MALE; MENTAL PERFORMANCE; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; RECALL; SPATIAL MEMORY; TESTOSTERONE BLOOD LEVEL; VERBAL MEMORY; VISUOMOTOR COORDINATION; WORKING MEMORY;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANILIDES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; COGNITION; DRUG ADMINISTRATION SCHEDULE; ESTRADIOL; GONADOTROPIN-RELEASING HORMONE; GOSERELIN; HUMANS; LEUPROLIDE; MALE; NEUROPSYCHOLOGICAL TESTS; NITRILES; PLACEBOS; PROSTATIC NEOPLASMS; TOSYL COMPOUNDS;

EID: 73949083164     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.06.012     Document Type: Article

References (64)

1. Adams M.R., Shah R.A., Janssen W.G.M., and Morrison J.H. Different modes of hippocampal plasticity in response to estrogen in young and aged female rats. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 8071-8076
2. Almeida O.P., Waterreus A., Spry N., Flicker L., and Martins R.N. One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology 29 (2004) 1071-1081
3. Beck, A., Steer, R., 1993. San Antonio, TX Patent No. The Psychological Corporation.
4. Beer T.M., Bland L.B., Bussiere J.R., Neiss M.B., Wersinger E.M., Garzotto M., Ryan C.W., and Janowsky J.S. Testosterone loss and estradiol administration modify memory in men. J. Urol. 175 (2006) 130-135
5. Belchetz P.E., Plant T.M., Nakai Y., Keogh E.J., and Knobil E. Hypophyseal responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science 202 (1978) 631-633
6. Benton A.L., and Hamsher K. Multilingual Aphasia Examination Iowa (1976), University of Iowa Press
7. Bimonte H.A., and Denenberg V.H. Estradiol facilitates performance as working memory load increases. Psychoneuroendocrinology 24 (1999) 161-173
8. Bremner W.J., Vitiello M.V., and Prinz P.N. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J. Clin. Endocrinol. Metab. 56 (1983) 1278-1281
9. Bussiere J.R., Beer T.M., Neiss M.B., and Janowsky J.S. Androgen deprivation impairs memory in older men. Behav. Neurosci. 119 (2005) 1429-1437
10. Canadian Pharmacists Association. Compendium of Pharmaceuticals and Specialties (CPS): The Canadian reference for health professionals (2007), Webcom Limited, Toronto
11. Cherrier M.M., Asthana S., Plymate S., Baker L., Matsumoto A.M., Peskind E., Raskind M.A., Brodkin K., Bremner W., Petrova A., LaTendresse S., and Craft S. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology 57 (2001) 80-88
12. Cherrier M.M., Rose A.L., and Higano C. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J. Urol. 170 (2003) 1808-1811
13. Cherrier M.M., Matsumoto A.M., Amory J.K., Ahmed S., Bremner W., Peskind E.R., Raskind M.A., Johnson M., and Craft S. The role of aromatization in testosterone supplementation - effects on cognition in older men. Neurology 64 (2005) 290-296
14. Cherrier, M.M., Montgomery, R., Nelson, P.S., Yu, E.Y., Higano, C.S., 2006. Prospective measurements of mood and cognition in men undergoing androgen deprivation therapy for biochemical relapse of prostate cancer. Poster presented at the 2006 Prostate Cancer Symposium.
15. Cherrier M.M., Aubin S., and Higano C.S. Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer. Psychooncology 18 (2008) 237-247
16. Cohen J. Statistical Power for the Behavioral Sciences (1988), Erlbaum, Hillsdale, NJ
17. Dohanich G.P. Gonadal steroids, learning and memory. In: Pfaff D.W., Arnold A.P., Etgen A.M., Fahrbach S.E., and Rubin R.T. (Eds). Hormones, Brain and Behavior (2002), Academic Press, San Diego 265-327
18. Edginton T.L., Jenkins V., Shilling V., and Bloomfield D.J. An investigative longitudinal pilot study of the cognitive effects of reversible hormone therapy for prostate cancer. Psychooncology 13 (2004) S21-S22
19. Ekstrom R.B., French J.W., Harman H.H., and Derman D. Kit of Factor-referenced Cognitive Tests (1976), Educational Testing Service, Princeton
20. Feldman H.A., Longcope C., Derby C.A., Johannes C.B., Araujo A.B., Coviello A.D., Bremner W.J., and McKinlay J.B. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab. 87 (2002) 589-598
21. Ferrini R.L., and Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am. J. Epidemiol. 147 (1998) 750-754
22. Folstein M.F., Folstein S.E., and McHugh P.R. Mini Mental State: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
23. Furr B.J.A. The development of Casodex (bicalutamide): preclinical studies. Eur. Urol. 29 (1996) 83-95
24. Gibbs R.B. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol. Aging 21 (2000) 107-116
25. Gibbs R.B. Testosterone and estradiol produce different effects on cognitive performance in male rats. Horm. Behav. 48 (2005) 268-277
26. Gibbs R.B., and Gabor R. Estrogen and cognition: applying preclinical findings to clinical perspectives. J. Neurosci. Res. 74 (2003) 637-643
27. Gray A., Feldman H.A., McKinlay J.B., and Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study. J. Clin. Endocrinol. Metab. 73 (1991) 1016-1025
28. Green H.J., Pakenham K.I., Headley B.C., Yaxley J., Nicol D.L., Mactaggart P.N., Swanson C., Watson R.B., and Gardiner R.A. Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int. 90 (2002) 427-432
29. Green H.J., Pakenham K.I., Headley B.C., Yaxley J., Nicol D.L., Mactaggart P.N., Swanson C.E., Watson R.B., and Gardiner R.A. Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. BJU Int. 93 (2004) 975-979
30. Halpern D.F. Sex Differences in Cognitive Abilities (1992), Lawrence Erlbaum Associates, Hillsdale
31. Harman S.M., Metter E.J., Tobin J.D., Pearson J., and Blackman M.R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J. Clin. Endocrinol. Metab. 86 (2001) 724-731
32. Jenkins V., Bloomfield D., and Shilling V. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study - reply. BJU Int. 96 (2005) 48-53
33. Jezierski M.K., and Sohrabji F. Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation. Neurobiol. Aging 22 (2001) 309-319
34. Joly F., Alibhai S.M.H., Galica J., Park A., Yi Q.-L., Wagner L., and Tannock I.F. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with non-metastatic prostate cancer. J. Urol. 176 (2006) 2443-2447
35. Kaufman A.S. Practice effects. In: Sternberg R.J. (Ed). Encyclopedia of Human Intelligence (1994), Macmillan Publishing Company, New York
36. Kaufman J., and Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev. 26 (2005) 833-876
37. Khosla S., Melton III L.J., Atkinson E.J., O'Fallon W.M., Klee G.G., and Riggs B.L. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J. Clin. Endocrinol. Metab. 82 (1998) 2266-2274
38. Maki P.M., Ernst M., London E.D., Mordecai K.L., Perschler P., Durso S.C., Brandt J., Dobs A., and Resnick S.M. Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function. J. Clin. Endocrinol. Metab. 92 (2007) 4107-4114
39. McEwen B.S. Interactions between hormones and nerve-tissue. Sci. Am. 235 (1976) 48-58
40. McEwen B.S. Neural gonadal-steroid actions. Science 211 (1981) 1303-1311
41. Morales A., and Lunenfeld B. International Society for the Study of the Aging Male. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. Aging Male 5 (2002) 74-86
42. Morley J.E. Testosterone (2000), Human Press, Totowa
43. Morley J.E., Kaiser F.E., and Perry III H.M. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 46 (1997) 410-413
44. Muller M., Aleman A., Grobbee D.E., de Haan E.H.F., and van der Schouw Y.T. Endogenous sex hormone levels and cognitive function in aging men - is there an optimal level?. Neurology 64 (2005) 866-871
45. Naftolin F., and Ryan K.J. The metabolism of androgen in central neuroendocrine tissues. J. Steroid Biochem. 6 (1975) 993-997
46. Nankin H.R., and Calkins J.H. Decreased bioavailable testosterone in aging normal and impotent men. J. Clin. Endocrinol. Metab. 63 (1986) 1418-1420
47. Resnick S.M., and Henderson V.W. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 288 (2002) 2170-2172
48. Rosner W. Errors in measurement of plasma free testosterone. J. Clin. Endocrinol. Metab. 82 (1997) 2014-2015
49. Salminen E., Portin R., Korpela J., Backman H., Parvinen L.M., Helenius H., and Nurmi M. Androgen deprivation and cognition in prostate cancer. Br. J. Cancer 89 (2003) 971-976
50. Salminen E.K., Portin R.I., Koskinen A., Helenius H., and Nurmi M. Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin. Cancer Res. 10 (2004) 7575-7582
51. Salminen E.K., Portin R.I., Koskinen A.I., Helenius H.Y.M., and Nurmi M.Y. Estradiol and cognition during androgen deprivation in men with prostate carcinoma. Cancer 103 (2005) 1381-1387
52. Sherwin B.B. Steroid hormones and cognitive functioning in aging men. J. Mol. Neurosci. 20 (2003) 385-393
53. Sherwin B.B., and Henry J.F. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front. Neuroendocrinol. 29 (2008) 88-113
54. Snyder P.J. Effects of age on testicular function and consequences of testosterone treatment. J. Clin. Endocrinol. Metab. 86 (2001) 2369-2372
55. Sodergard R., Backstrom T., Shanbhag V., and Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J. Steroid Biochem. 16 (1982) 801-810
56. Taxel P., Stevens M.C., Trahiotis M., Zimmerman J., and Kaplan R.F. The effect of short-term estradiol therapy on cognitive function in older men receiving hormonal suppression therapy for prostate cancer. J. Am. Geriatr. Soc. 52 (2004) 269-273
57. Thilers P.P., MacDonald S.W.S., and Herlitz A. The association between endogenous free testosterone and cognitive performance: a population-based study in 35 to 90 year-old men and women. Psychoneuroendocrinology 31 (2006) 565-576
58. Van den Beld A.W., de Jong F.H., Grobbee D.E., Pols H.A.P., and Lamberts S.W.J. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J. Clin. Endocrinol. Metab. 85 (2000) 3276-3282
59. Vandenberg S.G., and Kuse A.R. Mental rotations, a group test of three-dimensional spatial visualization. Percept. Mot. Skills 47 (1978) 599-604
60. Vermeulen A. Androgen replacement therapy in the aging male: a critical evaluation. J. Clin. Endocrinol. Metab. 86 (2001) 2380-2390
61. Vermeulen A., Kaufman J.M., Goemaere S., and Van Pottelberg I. Estradiol in elderly men. Aging Male 5 (2003) 98-102
62. Wechsler D.A. Wechsler Adult Intelligence Scale. third edition (1997), The Psychological Corporation, San Antonio
63. Wechsler D.A. Wechsler Memory Scale-Revised Manual (1987), The Psychological Corporation, San Antonio
64. Yonker J.E., Eriksson E., Nilsson L.G., and Herlitz A. Negative association of testosterone on spatial visualization in 35 to 80 year old men. Cortex 42 (2006) 376-386